Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction.
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
PURPOSE: Detection of occult carcinoma in patients with breast cancer may aid the establishment of prognosis and development of new therapeutic approaches. To improve on existing methods of detection, we have developed a reverse-transcriptase polymerase chain reaction (RT-PCR) assay for keratin 19 (K19) transcripts to identify mammary carcinoma cells in the peripheral blood and bone marrow of patients with breast cancer. PATIENTS AND METHODS: Peripheral-blood or bone marrow samples obtained from 34 patients with stages I to IV breast cancer and 39 control subjects without breast cancer were screened for K19 mRNA by nested primer PCR. RESULTS: In reconstitution experiments, K19 RT-PCR reliably detected 10 mammary carcinoma cells in 1 million normal peripheral-blood mononuclear (PBMN) cells. Four of 19 patients with stage IV breast cancer had detectable K19 transcript in peripheral blood. Five of six patients with histologically negative bone marrow biopsies following preablative chemotherapy and before autologous bone marrow transplant (BMT) were positive by this assay. Stem-cell apheresis harvests obtained from one of these patients and three additional patients immediately before BMT were all K19-negative. K19 RT-PCR analysis of CSF from a breast cancer patient with known carcinomatous meningitis was also positive. Thirty-eight of 39 non-breast cancer patients had negative K19 RT-PCR assays. The one exception was a patient with chronic myelogenous leukemia. CONCLUSION: RT-PCR of K19 is a sensitive, specific, and rapid method for detection of occult mammary carcinoma cells in the peripheral blood and bone marrow of patients with breast cancer. The presence of residual breast cancer cells in histologically normal bone marrow aspirates but not in stem-cell apheresis harvests is a frequent finding. This assay may be useful in diagnosing metastatic disease, as well as in monitoring the effectiveness of systemic therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moll, R., Franke, W. W., Schiller, D. L., Geiger, B., & Krepler, R. (1982) · Cell · doi:10.1016/0092-8674(82)90400-7 · Cited by 5,247
Gribben, J. G., Freedman, A. S., Neuberg, D., Roy, D. C., Blake, K. W., Woo, S. D., Grossbard, M. L., Rabinowe, S. N., Coral, F., Freeman, G. J., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199111283252201 · Cited by 668
Smith, B., Selby, P., Southgate, J., Pittman, K., Bradley, C., & Blair, G. E. (1991) · The Lancet · doi:10.1016/0140-6736(91)92100-g · Cited by 629
Illegitimate transcription: transcription of any gene in any cell type.
Chelly, J., Concordet, J. P., Kaplan, J. C., & Kahn, A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.8.2617 · Cited by 629
Sarkar, G., & Sommer, S. S. (1989) · Science · doi:10.1126/science.2565599 · Cited by 304
Diel, I., Kaufmann, M., Goerner, R., et al. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.10.1534 · Cited by 281
Schlimok, G., Funke, I., Bock, B., Schweiberer, B., Witte, J., & Riethmüller, G. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.5.831 · Cited by 201
Debus, E., Moll, R., Franke, W. W., Weber, K., & Osborn, M. (1984) · PubMed · Cited by 200
Mansi, J. L., Easton, D., Berger, U., Gazet, J.-C., Ford, H. T., Dearnaley, D., & Coombes, R. C. (1991) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(91)90413-8 · Cited by 199
Mansi, J. L., Berger, U., Easton, D., McDonnell, T., Redding, W. H., Gazet, J. C., McKinna, A., Powles, T. J., & Coombes, R. C. (1987) · BMJ · doi:10.1136/bmj.295.6606.1093 · Cited by 195
Cited by
Emerging molecular markers of cancer
Sidransky, D. (2002) · Nature Reviews Cancer · doi:10.1038/nrc755 · Cited by 662
Nucleic Acid-Based Methods for the Detection of Cancer
Sidransky, D. (1997) · Science · doi:10.1126/science.278.5340.1054 · Cited by 405
Pantel, K., Angstwurm, M., Riethmüller, G., Passlick, B., Izbicki, J., Thetter, O., & Häussinger, K. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91203-9 · Cited by 359
Bostick, P. J., Chatterjee, S., Chi, D. D., Huynh, K. T., Giuliano, A. E., Cote, R., & Hoon, D. S. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.8.2632 · Cited by 348
Stathopoulou, A., Vlachonikolis, I., Mavroudis, D., Perraki, M., Kouroussis, C., Apostolaki, S., Malamos, N., Kakolyris, S., Kotsakis, A., Xenidis, N., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.08.135 · Cited by 335
Burchill, S., Bradbury, M., Pittman, K., Southgate, J., Smith, B., & Selby, P. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.56 · Cited by 326
Circulating tumor cells (CTCs): Detection methods and their clinical relevance in breast cancer
Mostert, B., Sleijfer, S., Foekens, J. A., & Gratama, J. W. (2009) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2009.03.004 · Cited by 282
Zippelius, A., Kufer, P., Honold, G., Köllermann, M. W., Oberneder, R., Schlimok, G., Riethmüller, G., & Pantel, K. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.7.2701 · Cited by 277
DETECTION OF DISSEMINATED TUMOR CELLS IN PERIPHERAL BLOOD
Zieglschmid, V., Hollmann, C., & Böcher, O. (2005) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360590913696 · Cited by 272
Metadata
- Authors
- Datta, Y. H., Adams, P. T., Drobyski, W. R., Ethier, S. P., Terry, V. H., & Roth, M. S.
- Venue
- Journal of Clinical Oncology
- Published
- 1994-03
- Volume
- 12
- Issue
- 3
- Pages
- 475-482
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1748734394
- Cited by
- 422
- References
- 18
- FWCI
- 16.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.